Establishment of a Panel for services of preclinical contract research organizations (CROs)

dded to the panel who can provide comprehensive preclinical research services, ensuring rigorous evaluation of potential therapeutic agents in various disease contexts. The successful CROs will be able to offer preclinical services in various areas, including but not limited to the following – appli

cants may apply if they have expertise in one or more of the following areas: 1. Disease Model Development and Validation; 2. Pharmacological Testing; 3. Efficacy Studies; 4. Safety and Toxicology Testing; 5. Mechanistic Studies; 6. Custom